Is TriMas (TRS) Undervalued As Margin Gains And Higher EPS Guidance Lift Confidence?

TriMas (TRS) is back in focus after its latest quarterly earnings, where management reported margin expansion and higher profitability even as organic sales stayed broadly flat, and raised the lower end of full year EPS guidance.

See our latest analysis for TriMas.

The latest earnings news and continued share repurchases have come alongside a mixed trading pattern for TriMas. The company has a 10.03% year to date share price return but a 7.74% decline over the past 30 days, while the 1 year total shareholder return of 14.85% and 3 year total shareholder return of 57.95% point to a stronger longer term outcome than the recent pullback suggests.

If TriMas’s recent move has you thinking about where else capital is flowing, this is a good moment to scan 18 top founder-led companies

TriMas now trades below the average analyst target while internal estimates imply a tighter value range than the recent pullback suggests. Where does fair value really sit within that spread, and how wide is the safety margin?

Most Popular Narrative: 11.3% Undervalued

TriMas closed at $39.93, compared with a widely followed narrative fair value of $45.00. This frames the recent pullback as a valuation gap rather than a reset.

Ongoing strategic portfolio optimization, including the divestiture of non-core operations and reinvestment in higher-growth Packaging and Aerospace segments, positions TriMas to benefit from rising demand for recyclable, reusable, and innovative packaging solutions, directly supporting revenue growth.

Read the complete narrative.

Want to see how this TriMas story is built? The narrative leans heavily on tighter margins, steadier revenue compounding, and a future earnings multiple that assumes more than just cost cuts.

Result: Fair Value of $45 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this TriMas narrative can break if integration delays limit margin progress or if demand in key Aerospace and industrial end markets softens meaningfully.

Find out about the key risks to this TriMas narrative.

Another View On TriMas Valuation

The narrative fair value for TriMas sits at $45, which points to an 11.3% gap against the current $39.93 share price. However, our DCF model presents a different perspective and indicates a future cash flow value of $4.48, which implies the stock screens as expensive rather than cheap. Which framework feels more realistic for your own thesis on TriMas?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out TriMas for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 55 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With TriMas presenting both appealing and concerning signals, it makes sense to move quickly, review the underlying data, and determine your view on the overall balance of 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond TriMas?

If TriMas has your attention today, do not stop there. Widen your watchlist with a few focused stock ideas that could sharpen your next move.

• Spot potential value early by scanning screener containing 19 high quality undiscovered gems that pair solid fundamentals with less crowded investor attention.
• Build a steadier core by reviewing 81 resilient stocks with low risk scores that aim for resilience when markets turn choppy.
• Target stronger foundations by filtering for companies using the solid balance sheet and fundamentals stocks screener (45 results) and focus on those with healthier financial footing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com